Edwards Lifesciences exec sells 1,500 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Edwards Lifesciences Corp executive Daveen Chopra, CVP, TMTT & Surgical, reported an open-market sale of 1,500 shares of common stock. The shares were sold at a weighted average price of $84.6035 per share in multiple trades between $84.6002 and $84.6050. Following this transaction, Chopra directly holds 44,324 shares of Edwards Lifesciences common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,500 | $84.6035 | $127K |
Footnotes (1)
- F1. This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Key Figures
Key Terms
open-market sale financial
weighted average sale price financial
Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Edwards Lifesciences (EW) report for Daveen Chopra?
What role does Daveen Chopra hold at Edwards Lifesciences (EW)?
Was the Edwards Lifesciences (EW) insider sale executed in a single trade?
AI-generated analysis. How Rhea-AI works. Not financial advice.